good point - and i notice a little panic happening at the moment in India. India announced a couple of days ago that they dont have any relenza stockpile - i think just a few donated doses.what a massive market for future stockpile. 20% of their pop could afford to buy anti virals now - but govt has no chance to cover the recommended numbers for the whole population. Still if things keep getting worse for them you will see a lot of private buying pressure which would be able to be satisfied thru pharma wholesalers -private hospitals. It's this emerging pressure for relenza that i'm sure gsk is considering at the moment when considering how to boost current production targets behond 190m doses
BTA Price at posting:
$2.08 Sentiment: LT Buy Disclosure: Held
